Skip to main content
Erschienen in: Acta Neuropathologica 3/2009

01.03.2009 | Original Paper

Deletion of macrophage migration inhibitory factor attenuates neuronal death and promotes functional recovery after compression-induced spinal cord injury in mice

verfasst von: Yutaka Nishio, Masao Koda, Masayuki Hashimoto, Takahito Kamada, Shuhei Koshizuka, Katsunori Yoshinaga, Shin Onodera, Jun Nishihira, Akihiko Okawa, Masashi Yamazaki

Erschienen in: Acta Neuropathologica | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

Macrophage migration inhibitory factor (MIF) is a multipotential protein that acts as a proinflammatory cytokine, a pituitary hormone, and a cell proliferation and migration factor. The objective of this study was to elucidate the role of MIF in spinal cord injury (SCI) using female MIF knockout (KO) mice. Mouse spinal cord compression injury was produced by application of a static load (T8 level, 20 g, 5 min). We analyzed the motor function of the hind limbs and performed histological examinations. Hind-limb function recovered significantly in the KO mice starting from three weeks after injury. Cresyl-violet staining revealed that the number of surviving neurons in the KO mice was significantly larger than that of WT mice six weeks after injury. Immunohistochemical analysis revealed that the number of NeuN/caspase-3-active, double-positive, apoptotic neurons in the KO mice was significantly smaller than that of the WT mice 24 and 72 h after SCI. These results were related to in-vitro studies showing increased resistance of cerebellar granular neurons from MIF-KO animals to glutamate neurotoxicity. These results suggest that MIF existence hinders neuronal survival after SCI. Suppression of MIF may attenuate detrimental secondary molecular responses of the injured spinal cord.
Literatur
1.
Zurück zum Zitat Abe R, Shimizu T, Ohkawara A, Nishihira J (2000) Enhancement of macrophage migration inhibitory factor (MIF) expression in injured epidermis and cultured fibroblasts. Biochim Biophys Acta 1500:1–9PubMed Abe R, Shimizu T, Ohkawara A, Nishihira J (2000) Enhancement of macrophage migration inhibitory factor (MIF) expression in injured epidermis and cultured fibroblasts. Biochim Biophys Acta 1500:1–9PubMed
2.
Zurück zum Zitat Akoum A, Kong J, Metz C, Beaumont MC (2002) Spontaneous and stimulated secretion of monocyte chemotactic protein-1 and macrophage migration inhibitory factor by peritoneal macrophages in women with and without endometriosis. Fertil Steril 77:989–994PubMedCrossRef Akoum A, Kong J, Metz C, Beaumont MC (2002) Spontaneous and stimulated secretion of monocyte chemotactic protein-1 and macrophage migration inhibitory factor by peritoneal macrophages in women with and without endometriosis. Fertil Steril 77:989–994PubMedCrossRef
3.
Zurück zum Zitat Bernhagen J, Calandra T, Mitchell RA et al (1993) MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365:756–759PubMedCrossRef Bernhagen J, Calandra T, Mitchell RA et al (1993) MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365:756–759PubMedCrossRef
4.
Zurück zum Zitat Bloom BR, Shevach E (1975) Requirement for T cells in the production of migration inhibitory factor. J Exp Med 142:1306–1311PubMedCrossRef Bloom BR, Shevach E (1975) Requirement for T cells in the production of migration inhibitory factor. J Exp Med 142:1306–1311PubMedCrossRef
5.
Zurück zum Zitat Farooque M (2000) Spinal cord compression injury in the mouse: presentation of a model including assessment of motor dysfunction. Acta Neuropathol 100:13–22PubMedCrossRef Farooque M (2000) Spinal cord compression injury in the mouse: presentation of a model including assessment of motor dysfunction. Acta Neuropathol 100:13–22PubMedCrossRef
6.
Zurück zum Zitat Farooque M, Isaksson J, Olsson Y (2001) Improved recovery after spinal cord injury in neuronal nitric oxide synthase-deficient mice but not in TNF-alpha-deficient mice. J Neurotrauma 18:105–114PubMedCrossRef Farooque M, Isaksson J, Olsson Y (2001) Improved recovery after spinal cord injury in neuronal nitric oxide synthase-deficient mice but not in TNF-alpha-deficient mice. J Neurotrauma 18:105–114PubMedCrossRef
7.
Zurück zum Zitat Fujimoto S (1997) Identification of macrophage migration inhibitory factor (MIF) in rat spinal cord and its kinetics on experimental spinal cord injury. Hokkaido Igaku Zasshi 72:409–430 JapanesePubMed Fujimoto S (1997) Identification of macrophage migration inhibitory factor (MIF) in rat spinal cord and its kinetics on experimental spinal cord injury. Hokkaido Igaku Zasshi 72:409–430 JapanesePubMed
8.
Zurück zum Zitat Honma N, Koseki H, Akasaka T et al (2000) Deficiency of the macrophage migration inhibitory factor gene has no significant effect on endotoxaemia. Immunology 100:84–90PubMedCrossRef Honma N, Koseki H, Akasaka T et al (2000) Deficiency of the macrophage migration inhibitory factor gene has no significant effect on endotoxaemia. Immunology 100:84–90PubMedCrossRef
9.
Zurück zum Zitat Koda M, Nishio Y, Hashimoto M et al (2004) Up-regulation of macrophage migration- inhibitory factor expression after compression-induced spinal cord injury in rats. Acta Neuropathol 108:31–36PubMedCrossRef Koda M, Nishio Y, Hashimoto M et al (2004) Up-regulation of macrophage migration- inhibitory factor expression after compression-induced spinal cord injury in rats. Acta Neuropathol 108:31–36PubMedCrossRef
10.
Zurück zum Zitat Niino M, Ogata A, Kikuchi S, Tashiro K, Nishihira J (2000) Macrophage migration inhibitory factor in the cerebrospinal fluid of patients with conventional and optic-spinal forms of multiple sclerosis and neuro-Behçet’s disease. J Neurol Sci 179(S 1–2):127–131PubMedCrossRef Niino M, Ogata A, Kikuchi S, Tashiro K, Nishihira J (2000) Macrophage migration inhibitory factor in the cerebrospinal fluid of patients with conventional and optic-spinal forms of multiple sclerosis and neuro-Behçet’s disease. J Neurol Sci 179(S 1–2):127–131PubMedCrossRef
11.
Zurück zum Zitat Nishihira J (1998) Novel pathophysiological aspects of macrophage migration inhibitory factor (review). Int J Mol Med 2:17–28PubMed Nishihira J (1998) Novel pathophysiological aspects of macrophage migration inhibitory factor (review). Int J Mol Med 2:17–28PubMed
12.
Zurück zum Zitat Ogata A, Nishihira J, Suzuki T, Nagashima K, Tashiro K (1998) Identification of macrophage migration inhibitory factor mRNA expression in neural cells of the rat brain by in situ hybridization. Neurosci Lett 246:173–177PubMedCrossRef Ogata A, Nishihira J, Suzuki T, Nagashima K, Tashiro K (1998) Identification of macrophage migration inhibitory factor mRNA expression in neural cells of the rat brain by in situ hybridization. Neurosci Lett 246:173–177PubMedCrossRef
13.
Zurück zum Zitat Oshima S, Onodera S, Amizuka N et al (2006) Macrophage migration inhibitory factor-deficient mice are resistant to ovariectomy-induced bone loss. FEBS Lett 580:1251–1256PubMedCrossRef Oshima S, Onodera S, Amizuka N et al (2006) Macrophage migration inhibitory factor-deficient mice are resistant to ovariectomy-induced bone loss. FEBS Lett 580:1251–1256PubMedCrossRef
14.
Zurück zum Zitat Plesnila N, von Baumgarten L, Retiounskaia M et al (2007) Delayed neuronal death after brain trauma involves p53-dependent inhibition of NF-kappaB transcriptional activity. Cell Death Differ 14:1529–1541PubMedCrossRef Plesnila N, von Baumgarten L, Retiounskaia M et al (2007) Delayed neuronal death after brain trauma involves p53-dependent inhibition of NF-kappaB transcriptional activity. Cell Death Differ 14:1529–1541PubMedCrossRef
15.
Zurück zum Zitat Raivich G, Liu ZQ, Kloss CU et al (2002) Cytotoxic potential of proinflammatory cytokines: combined deletion of TNF receptors TNFR1 and TNFR2 prevents motoneuron cell death after facial axotomy in adult mouse. Exp Neurol 178:186–193PubMedCrossRef Raivich G, Liu ZQ, Kloss CU et al (2002) Cytotoxic potential of proinflammatory cytokines: combined deletion of TNF receptors TNFR1 and TNFR2 prevents motoneuron cell death after facial axotomy in adult mouse. Exp Neurol 178:186–193PubMedCrossRef
16.
Zurück zum Zitat Santos LL, Morand EF (2006) The role of macrophage migration inhibitory factor in the inflammatory immune response and rheumatoid arthritis. Wien Med Wochenschr 156:8–11 ReviewCrossRef Santos LL, Morand EF (2006) The role of macrophage migration inhibitory factor in the inflammatory immune response and rheumatoid arthritis. Wien Med Wochenschr 156:8–11 ReviewCrossRef
17.
Zurück zum Zitat Stosic-Grujicic S, Stojanovic I, Maksimovic-Ivanic D et al (2008) Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus. J Cell Physiol 215:665–675PubMedCrossRef Stosic-Grujicic S, Stojanovic I, Maksimovic-Ivanic D et al (2008) Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus. J Cell Physiol 215:665–675PubMedCrossRef
18.
Zurück zum Zitat Weber UJ, Bock T, Buschard K, Pakkenberg B (1997) Total number and size distribution of motor neurons in the spinal cord of normal and EMC-virus infected mice—a stereological study. J Anat 191:347–353PubMedCrossRef Weber UJ, Bock T, Buschard K, Pakkenberg B (1997) Total number and size distribution of motor neurons in the spinal cord of normal and EMC-virus infected mice—a stereological study. J Anat 191:347–353PubMedCrossRef
19.
Zurück zum Zitat Zhao Y, Shimizu T, Nishihira J et al (2005) Tissue regeneration using macrophage migration inhibitory factor-impregnated gelatin microbeads in cutaneous wounds. Am J Pathol 167:1519–1529PubMed Zhao Y, Shimizu T, Nishihira J et al (2005) Tissue regeneration using macrophage migration inhibitory factor-impregnated gelatin microbeads in cutaneous wounds. Am J Pathol 167:1519–1529PubMed
Metadaten
Titel
Deletion of macrophage migration inhibitory factor attenuates neuronal death and promotes functional recovery after compression-induced spinal cord injury in mice
verfasst von
Yutaka Nishio
Masao Koda
Masayuki Hashimoto
Takahito Kamada
Shuhei Koshizuka
Katsunori Yoshinaga
Shin Onodera
Jun Nishihira
Akihiko Okawa
Masashi Yamazaki
Publikationsdatum
01.03.2009
Verlag
Springer-Verlag
Erschienen in
Acta Neuropathologica / Ausgabe 3/2009
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-008-0476-x

Weitere Artikel der Ausgabe 3/2009

Acta Neuropathologica 3/2009 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.